Daniel Hicklin

Person

Montclair, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Activatable cytokine polypeptides and methods of use thereof
- Patent number 12,076,371
- Issue date Sep 3, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable cytokine polypeptides and methods of use thereof
- Patent number 12,036,266
- Issue date Jul 16, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,981,716
- Issue date May 14, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Separation moieties and methods of use thereof
- Patent number 11,739,132
- Issue date Aug 29, 2023
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of uses thereof
- Patent number 11,590,224
- Issue date Feb 28, 2023
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,535,658
- Issue date Dec 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin 12 polypeptides and methods of use thereof
- Patent number 11,453,710
- Issue date Sep 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of use thereof
- Patent number 11,453,720
- Issue date Sep 27, 2022
- Potenza Therapeutics, Inc.
- Nels P. Nielson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,352,403
- Issue date Jun 7, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-neuropilin antigen-binding proteins and methods of use thereof
- Patent number 11,186,644
- Issue date Nov 30, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of detecting TIM-3 using antibody molecules to TIM-3
- Patent number 11,155,620
- Issue date Oct 26, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-GITR antigen-binding proteins and methods of use thereof
- Patent number 10,988,545
- Issue date Apr 27, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,981,990
- Issue date Apr 20, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Grant
Activatable interleukin-2 polypeptides
- Patent number 10,696,724
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin 12 polypeptides
- Patent number 10,696,723
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of use thereof
- Patent number 10,507,244
- Issue date Dec 17, 2019
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,472,419
- Issue date Nov 12, 2019
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunomodulatory oncolytic adenoviral vectors, and methods of produ...
- Patent number 10,232,053
- Issue date Mar 19, 2019
- Trieza Therapeutics, Inc.
- Daniel Hicklin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-neuropilin antigen-binding proteins and methods of use thereof
- Patent number 10,227,413
- Issue date Mar 12, 2019
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 9,884,913
- Issue date Feb 6, 2018
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of use thereof
- Patent number 9,713,641
- Issue date Jul 25, 2017
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 9,605,070
- Issue date Mar 28, 2017
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted piperidines that increase p53 activity and the uses the...
- Patent number 8,859,776
- Issue date Oct 14, 2014
- Merck Sharp & Dohme Corp.
- Stephane L. Bogen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against vascular endothelial growth factor receptor-1
- Patent number 8,143,025
- Issue date Mar 27, 2012
- ImClone LLC
- Yan Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against vascular endothelial growth factor receptor-1
- Patent number 7,972,596
- Issue date Jul 5, 2011
- ImClone LLC
- Yan Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody antagonists of VE-cadherin without adverse effects on vasc...
- Patent number 7,371,574
- Issue date May 13, 2008
- ImClone Systems, Inc.
- Fang Liao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized hepatitis B e antigen suitable for immunoassays
- Patent number 5,501,948
- Issue date Mar 26, 1996
- ImClone Systems Incorporated
- Daniel J. Hicklin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IL-2 PRODRUG
- Publication number 20240374687
- Publication date Nov 14, 2024
- Werewolf Therapeutics, Inc.
- Jose Andres SALMERON-GARCIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240358796
- Publication date Oct 31, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240262880
- Publication date Aug 8, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDUCIBLE IL-2 AND PD-1/PD-L1 COMBINATION THERAPY
- Publication number 20240216470
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCIBLE CYTOKINE PRODRUG AND PD-1/PD-L1 COMBINATION THERAPY
- Publication number 20240216505
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERFERON POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240216474
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240174725
- Publication date May 30, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE IL-12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240043488
- Publication date Feb 8, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Activatable Cytokine Polypeptides and Methods of Use Thereof
- Publication number 20240033326
- Publication date Feb 1, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230374093
- Publication date Nov 23, 2023
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20230272028
- Publication date Aug 31, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230056051
- Publication date Feb 23, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230051423
- Publication date Feb 16, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220324930
- Publication date Oct 13, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20220220181
- Publication date Jul 14, 2022
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220185883
- Publication date Jun 16, 2022
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220133889
- Publication date May 5, 2022
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEUROPILIN ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20220098312
- Publication date Mar 31, 2022
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220056096
- Publication date Feb 24, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210403524
- Publication date Dec 30, 2021
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODU...
- Publication number 20210393803
- Publication date Dec 23, 2021
- Trieza Therapeutics, Inc.
- Daniel HICKLIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-GITR ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20210269542
- Publication date Sep 2, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210130430
- Publication date May 6, 2021
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20210115102
- Publication date Apr 22, 2021
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200308277
- Publication date Oct 1, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283490
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283489
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200223917
- Publication date Jul 16, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20200101158
- Publication date Apr 2, 2020
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20200095324
- Publication date Mar 26, 2020
- Potenza Therapeutics, Inc.
- Nels P. Nielson
- C07 - ORGANIC CHEMISTRY

Daniel Hicklin

Person

Patents Grantslast 30 patents

Activatable cytokine polypeptides and methods of use thereof

Activatable cytokine polypeptides and methods of use thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Separation moieties and methods of use thereof

Anti-TIGIT antigen-binding proteins and methods of uses thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Activatable interleukin 12 polypeptides and methods of use thereof

Anti-TIGIT antigen-binding proteins and methods of use thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Anti-neuropilin antigen-binding proteins and methods of use thereof

Method of detecting TIM-3 using antibody molecules to TIM-3

Anti-GITR antigen-binding proteins and methods of use thereof

Antibody molecules to TIM-3 and uses thereof

Activatable interleukin-2 polypeptides

Activatable interleukin 12 polypeptides

Anti-TIGIT antigen-binding proteins and methods of use thereof

Antibody molecules to TIM-3 and uses thereof

Immunomodulatory oncolytic adenoviral vectors, and methods of produ...

Anti-neuropilin antigen-binding proteins and methods of use thereof

Antibody molecules to TIM-3 and uses thereof

Anti-TIGIT antigen-binding proteins and methods of use thereof

Antibody molecules to TIM-3 and uses thereof

Substituted piperidines that increase p53 activity and the uses the...

Antibodies against vascular endothelial growth factor receptor-1

Antibodies against vascular endothelial growth factor receptor-1

Antibody antagonists of VE-cadherin without adverse effects on vasc...

Stabilized hepatitis B e antigen suitable for immunoassays

Patents Applicationslast 30 patents

IL-2 PRODRUG

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

INDUCIBLE IL-2 AND PD-1/PD-L1 COMBINATION THERAPY

INDUCIBLE CYTOKINE PRODRUG AND PD-1/PD-L1 COMBINATION THERAPY

ACTIVATABLE INTERFERON POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE IL-12 POLYPEPTIDES AND METHODS OF USE THEREOF

Activatable Cytokine Polypeptides and Methods of Use Thereof

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

ANTI-NEUROPILIN ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODU...

ANTI-GITR ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF